Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
NEOGEN® and Gencove Launch InfiniSEEK™ -- The First Whole Genome and Genotyping Sequencing Solution for Cattle Breeders | ||
By: PR Newswire Association LLC. - 12 May 2022 | Back to overview list |
|
InfiniSEEK's unique technology enables simultaneous low-pass whole genome sequencing and high-coverage genotyping at regions of interest. LINCOLN, Neb. and NEW YORK, May 12, 2022 /PRNewswire/ -- NEOGEN® Corporation (NASDAQ: NEOG) and Gencove, the leading low-pass whole genome sequencing and analysis software company, today announced the launch of InfiniSEEK™, an innovative, cost-effective solution for whole genome sequencing and targeted SNP analysis. Combining NEOGEN's world-class genomic solutions and services with Gencove's low-pass sequencing and analytics software, the solution can deliver genomic insights to help advance cattle breeding programs worldwide. "NEOGEN offers innovative, high quality, value-added genomic technologies to the agrigenomics industry," said Dr. Jason Lilly, NEOGEN's Vice President of International Business. "With the launch of InfiniSEEK, our customers now have a data-rich, cost-efficient way to get genome-wide sequence data, specific genetic traits, and parentage markers simultaneously with excellent accuracy to characterize cattle across the world. We are excited to add this new solution to NEOGEN's portfolio." "Gencove developed a process that simultaneously yields low-pass whole genome sequencing and high coverage genotyping at pre-selected loci in a single molecular reaction," said Dr. Joseph Pickrell, co-founder and CEO of Gencove. "InfiniSEEK is NEOGEN's first commercial product built on the Gencove software and analysis platform, and we are thrilled it will be deployed through NEOGEN's best in class genomics offering services." With InfiniSEEK, the industry now has a platform to:
InfiniSEEK has been rigorously validated, and results demonstrate low-pass genome-wide sequencing to be greater than 99 percent concordant to deep whole-genome sequencing and can offer even higher, clinical-grade accuracy at specific regions of interest. About Gencove About NEOGEN NEOGEN CONTACT: Madeline Moore, Senior Marketing Manager GENCOVE CONTACT: Kristi Ashton View original content:https://www.prnewswire.com/news-releases/neogen-and-gencove-launch-infiniseek--the-first-whole-genome-and-genotyping-sequencing-solution-for-cattle-breeders-301546047.html SOURCE NEOGEN Corporation |
||
|
||
Copyright 2022 PR Newswire Association LLC. | Back to overview list |